on 02 Nov 2021
Last Applicant/ Owned by
2001 L St NW Suite 500, #50108
Washington
DC
20036
Serial Number
90550274 filed on 26th Feb 2021
Registration Number
6549474 registered on 02th Nov 2021
Filing Basis
1. use application currently
Disclaimer
NO DATA
providing medical information in the nature of providing and preparing medical treatment protocols for individuals infected with COVID-19 and other infectious diseases; Providing a web site that gives medical information about the treatment of COVID-19 and other infectious diseases Development of quality control standards for testing and medical treatment procedures for individuals infected with Read More
Development of quality control standards for testing and medical treatment procedures for individuals infected with COVID-19 and other infectious diseases; Research and development of pharmaceuticals and medical procedures for the treatment of individuals infected with COVID-19 and other infectious diseases; Scientific study and research regarding effective treatment protocols for individuals infected with COVID-19 and other infectious diseases
22nd Jul 2020
22nd Jul 2020
providing medical information in the nature of providing and preparing medical treatment protocols for individuals infected with COVID-19 and other infectious diseases; Providing a web site that gives medical information about the treatment of COVID-19 and other infectious diseases
22nd Jul 2020
22nd Jul 2020
No 90550274
No Service Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
02th Nov 2021 | REGISTERED-SUPPLEMENTAL REGISTER |
07th Oct 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
07th Oct 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
07th Oct 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
28th Sep 2021 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
27th Sep 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
27th Sep 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
27th Sep 2021 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
24th Sep 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
23rd Sep 2021 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED |